These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Donor notification for positive non-A, non-B hepatitis surrogate testing. Brubaker DB; Ukkestad S; Myhre BA West J Med; 1987 May; 146(5):620. PubMed ID: 3109126 [No Abstract] [Full Text] [Related]
3. [Screening of blood donors for the prevention of non-A, non-B hepatitis]. Seidl S Dtsch Med Wochenschr; 1983 Jan; 108(4):123-4. PubMed ID: 6402351 [No Abstract] [Full Text] [Related]
4. Screening for hepatitis C virus antibody. Lancet; 1989 Aug; 2(8661):505. PubMed ID: 2570213 [No Abstract] [Full Text] [Related]
5. Screening for hepatitis C virus antibody in plasma for fractionation. Habibi B; Garretta M Lancet; 1990 Apr; 335(8693):855-6. PubMed ID: 1969577 [No Abstract] [Full Text] [Related]
7. Role of screening in prevention and treatment. Kane M; Alter M; Esteban R; Rizzetto M Gut; 1993; 34(2 Suppl):S45-7. PubMed ID: 8314491 [TBL] [Abstract][Full Text] [Related]
8. Anti-HBc testing in an effort to reduce the incidence of posttransfusion non-A, non-B hepatitis. Kline WE Beitr Infusionther Klin Ernahr; 1987; 18():6-12. PubMed ID: 3125834 [No Abstract] [Full Text] [Related]
9. Clinical value of the guanase screening test in donor blood for prevention of posttransfusional non-A, non-B hepatitis. Ito S; Tsuji Y; Kitagawa N; Akihiko I; Syundo J; Tamura Y; Kishi S; Mori H Hepatology; 1988; 8(2):383-4. PubMed ID: 3128469 [TBL] [Abstract][Full Text] [Related]
10. [Selection of donors in the prevention of post-transfusion viral hepatitis]. Massaro AL Riv Emoter Immunoematol; 1985; 32(2):156-9. PubMed ID: 3937210 [No Abstract] [Full Text] [Related]
12. Prevention of posttransfusional non-A, non-B hepatitis using the screening test for guanase activity of donor blood. Ito S; Tsuji Y Gastroenterol Jpn; 1988 Apr; 23(2):153-9. PubMed ID: 3133278 [TBL] [Abstract][Full Text] [Related]